Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2022-03-18 00:00:00 ET · period of report 2022-03-17 · accession 0000899243-22-011614 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-18 | 2022-03-17+ | CORT | Robb Gary Charles | Chief Business Off | S - Sale | $24.68 | -12.5K | 76.4K | -14% | -$308.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-18 | S | D | 4,988 | $24.67 | 71,446 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-17 | S | D | 7,512 | $24.68 | 76,434 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $24.67 to $24.70. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. |